Show simple item record

dc.contributor.authorNajafzadeh, Mojgan*
dc.contributor.authorAnderson, Diana*
dc.date.accessioned2018-05-01T08:50:33Z
dc.date.available2018-05-01T08:50:33Z
dc.date.issued2017-11-13
dc.identifier.citationNajafzadeh M and Anderson D (2017) Nanoparticles in Biomedicine and Medicine, and Possible Clinical Toxicological Application of Peripheral Lymphocytes in the Risk Assessment Process for Susceptible Disease State Individuals. In: Dhawan A, Anderson D and Shanker R (Eds) Nanotoxicology: Experimental and Computational Perspectives. Cambridge, UK: Royal Society of Chemistry.en_US
dc.identifier.urihttp://hdl.handle.net/10454/15721
dc.descriptionNoen_US
dc.description.abstractNanoparticle usage has emerged in the medical field as a technology well-suited to the diagnosis and treatment of a variety of disease states. The distinctive characteristics of engineered nanoparticles (ENPs) such as higher surface-area-to-volume ratios find various applications in personal care products, food packaging, drug-delivery systems, therapeutics, biosensors and others. The exponential increase in ENP-containing consumer products in the last decade has also increased their inadvertent release into the environment and the debate relating to their adverse effects on human and environmental health. The use of NPs for different functions in human studies has significantly increased the application of NPs in biomedicine, for instance, imaging of cell and tissues, drug delivery and sensing of target molecules. These nanomaterials have been investigated for the treatment and detection of various pathological conditions. There are suitable biological systems now available in man using peripheral blood lymphocytes to determine the effect of NPs in various disease states.en_US
dc.language.isoenen_US
dc.relation.isreferencedbyhttp://pubs.rsc.org/en/content/chapter/bk9781782621584-00133/978-1-78262-392-2en_US
dc.subjectNanoparticlesen_US
dc.subjectPeripheral lymphocytesen_US
dc.subjectRisk assessmenten_US
dc.subjectMedicineen_US
dc.subjectBiomedicineen_US
dc.titleNanoparticles in Biomedicine and Medicine, and Possible Clinical Toxicological Application of Peripheral Lymphocytes in the Risk Assessment Process for Susceptible Disease State Individualsen_US
dc.status.refereedNoen_US
dc.typeBook chapteren_US
dc.type.versionNo full-text in the repositoryen_US


Item file(s)

Thumbnail
Name:
Chapter 11-Diana-RS26-02-17.pdf
Size:
423.6Kb
Format:
PDF
Description:
Keep suppressed - no permission ...

This item appears in the following Collection(s)

Show simple item record